Evidence map›Paper›PMID 35086939›Full record

Observational studyJournal of neurology, neurosurgery, and psychiatry2022

Amantadine treatment is associated with improved consciousness in patients with non-traumatic brain injury.

Lena Rühl, Joji B Kuramatsu, Jochen A Sembill, Bernd Kallmünzer, Dominik Madzar, Stefan T Gerner, Antje Giede-Jeppe, Stefanie Balk, Tamara Mueller, Jakob Jäger and 3 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Journal of neurology, neurosurgery, and psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Restoring consciousness with pharmacologic therapy: Mechanisms, targets, and future directions.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Lena RühlDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Joji B KuramatsuDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0002-7630-7880
Jochen A SembillDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Bernd KallmünzerDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Dominik MadzarDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0001-8680-9668
Stefan T GernerDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.ORCID 0000-0001-6020-8290
Antje Giede-JeppeDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Stefanie BalkDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Tamara MuellerDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Jakob JägerDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Stefan SchwabDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Hagen B HuttnerDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Maximilian I SprügelDepartment of Neurology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany maximilian.spruegel@uk-erlangen.de.ORCID 0000-0002-1679-9553
Friedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study determined the effect of amantadine treatment on consciousness in patients with non-traumatic brain injury.

methodsWe pooled individual patient data of five single-centre observational studies to determine the effect of amantadine treatment among patients with ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, community-acquired bacterial meningitis and status epilepticus, admitted between January 2012 and December 2015 and ventilated ≥7 days. Patient selection and multivariable regression modelling were used to adjust for differences in intergroup comparison and for parameters associated with consciousness. Improvement of consciousness 5 days after treatment initiation was defined as primary outcome. Secondary outcomes included Glasgow Coma Scale (GCS) at day 5 and GCS at day 10, rate of ICU delirium, epileptic seizures and all-cause mortality at 90 days.

resultsOverall, 84 of 294 (28.6%) eligible patients received amantadine. Amantadine treatment was associated with improvement of consciousness at day 5 (amantadine: 86.9% vs control: 54.0%; absolute difference: 32.9 (20.0-44.2); adjusted OR (aOR): 5.71 (2.50-13.05), p<0.001). Secondary outcomes showed differences in GCS 5 days (9 (8-11) vs 6 (3-9), p<0.001) and GCS 10 days (10(8-11) vs 9(6-11),p=0.003) after treatment initiation. There were no significant differences regarding all-cause mortality (aOR: 0.89 (0.44-1.82), p=0.758) and ICU delirium (aOR: 1.39 (0.58-3.31), p=0.462). Rate of epileptic seizures after initiation of amantadine treatment was numerically higher in the amantadine group (amantadine: 10.7% vs control: 3.0%; absolute difference: 7.7 (0.3-16.4); aOR: 3.68 (0.86-15.71), p=0.079).

conclusionsAmantadine treatment is associated with improved consciousness among patients with different types of non-traumatic brain injury in this observational cohort analysis. Epileptic seizures should be considered as potential side effects and randomised controlled trials are needed to confirm these findings.

Indexed as

Brain InjuriesBrain IschemiaDeliriumStrokeAmantadineConsciousnessGlasgow Coma ScaleHumansSeizuresAmantadineacquired brain injuryconsciousnessepilepsystrokesubarachnoid haemorrhage

Identifiers

PMID35086939
PMCPMC9148986
OpenAlexW4210679888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.